Items where authors include "Sifuentes-Osornio, J"

Article

Han, MK, Antila, M, Ficker, JH et al. (17 more authors) (2022) Ruxolitinib in addition to standard of care for the treatment of patients admitted to hospital with COVID-19 (RUXCOVID): a randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet Rheumatology, 4 (5). e351-e361. ISSN 2665-9913